Prolonged Atrial Natriuretic Peptide Exposure Stimulates Guanylyl Cyclase-a Degradation
Overview
Authors
Affiliations
Natriuretic peptide receptor-A (NPR-A), also known as guanylyl cyclase-A, is a transmembrane receptor guanylyl cyclase that is activated by the cardiac hormones atrial natriuretic peptide and B-type natriuretic peptide. Although ligand-dependent NPR-A degradation (also known as down-regulation) is widely acknowledged in human and animal models of volume overload, down-regulation in cultured cells is controversial. Here, we examined the effect of ANP exposure on cellular NPR-A levels as a function of time. Relative receptor concentrations were estimated using guanylyl cyclase and immunoblot assays in a wide variety of cell lines that endogenously or exogenously expressed low or high numbers of receptors. ANP exposures of 1 h markedly reduced hormone-dependent but not detergent-dependent guanylyl cyclase activities in membranes from exposed cells. However, 1-h ANP exposures did not significantly reduce NPR-A concentrations in any cell line. In contrast, exposures of greater than 1 h reduced receptor concentrations in a time-dependent manner. The time required for half of the receptors to be degraded (t(1/2)) in primary bovine aortic endothelial and immortalized HeLa cells was approximately 8 h. In contrast, a 24-h exposure of ANP to 293T cells stably overexpressing NPR-A caused less than half of the receptors to be degraded. To our knowledge, this is the first report to directly measure NPR-A down-regulation in endogenously expressing cells. We conclude that down-regulation is a universal property of NPR-A but is relatively slow and varies with receptor expression levels and cell type.
Mani I, Pandey K Cell Signal. 2019; 60:17-30.
PMID: 30951863 PMC: 6836728. DOI: 10.1016/j.cellsig.2019.03.022.
Schmidt H, Dickey D, Dumoulin A, Octave M, Robinson J, Kuhn R J Neurosci. 2018; 38(45):9768-9780.
PMID: 30249793 PMC: 6222061. DOI: 10.1523/JNEUROSCI.0495-18.2018.
Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.
Fu S, Ping P, Wang F, Luo L J Biol Eng. 2018; 12:2.
PMID: 29344085 PMC: 5766980. DOI: 10.1186/s13036-017-0093-0.
Dickey D, Edmund A, Otto N, Chaffee T, Robinson J, Potter L J Biol Chem. 2016; 291(21):11385-93.
PMID: 26980729 PMC: 4900282. DOI: 10.1074/jbc.M115.704015.
Mani I, Garg R, Pandey K Am J Physiol Renal Physiol. 2015; 310(1):F68-84.
PMID: 26377794 PMC: 4675805. DOI: 10.1152/ajprenal.00205.2015.